Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genevieve M Monsees

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Genetic Epidemiology|April 15, 2009
Genome-wide association scans for secondary traits using case-control samplesGenevieve M Monsees, Rulla M Tamimi, Peter Kraft
Breast Cancer Research and Treatment|May 25, 2010
Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer riskGenevieve M Monsees, Peter Kraft, Stephen J Chanock, et al.
International Journal of Cancer|April 5, 2012
Circadian genes and breast cancer susceptibility in rotating shift workersGenevieve M Monsees, Peter Kraft, Susan E Hankinson, et al.
Journal of the National Cancer Institute|October 25, 2011
Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancerGenevieve M Monsees, Kathleen E Malone, Mei-Tzu C Tang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Genetic Epidemiology|April 15, 2009
Genome-wide association scans for secondary traits using case-control samplesGenevieve M Monsees, Rulla M Tamimi, Peter Kraft
Breast Cancer Research and Treatment|May 25, 2010
Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer riskGenevieve M Monsees, Peter Kraft, Stephen J Chanock, et al.
International Journal of Cancer|April 5, 2012
Circadian genes and breast cancer susceptibility in rotating shift workersGenevieve M Monsees, Peter Kraft, Susan E Hankinson, et al.
Journal of the National Cancer Institute|October 25, 2011
Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancerGenevieve M Monsees, Kathleen E Malone, Mei-Tzu C Tang, et al.
Pageof 1